Refractory Anti-NMDA Receptor Encephalitis Managed With Rituximab in a Resource-Limited Setting.

Rituxan (rituximab) - Roche

Refractory Anti-NMDA Receptor Encephalitis Managed With Rituximab in a Resource-Limited Setting. (PubMed, Am J Ther) - Sep 22, 2026 - No abstract available
Journal • CNS Disorders

http://www.ncbi.nlm.nih.gov/pubmed/42764428

Maham Mehmood; Muhammad H Javaid; Muhammad R Fida; Okasha Tahir

Sep 22, 2026